Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Public ClinicalTrials.gov record NCT02389946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the safety and efficacy of the Orsiro Sirolimus Eluting Coronary Stent System in the treatment of subjects with up to three native de novo or restenotic (standard PTCA only) coronary artery lesions compared to the Xience coronary stent system.
Study identification
- NCT ID
- NCT02389946
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,334 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2015 (Type not available)
- Primary completion
- Apr 2017 (Actual)
- Completion
- Mar 2021 (Actual)
- Last update posted
- Aug 3, 2022
2015 – 2021
United States locations
- U.S. sites
- 55
- U.S. states
- 25
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Fairhope | Alabama | 36535 | — |
| Not listed | Concord | California | 94520 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Atlanta | Georgia | 30309 | — |
| Not listed | Urbana | Illinois | 61801 | — |
| Not listed | Fort Wayne | Indiana | 46845 | — |
| Not listed | Baltimore | Maryland | 21218 | — |
| Not listed | Boston | Massachusetts | 02120 | — |
| Not listed | Bay City | Michigan | 48708 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Lansing | Michigan | 48912 | — |
| Not listed | Pontiac | Michigan | 48341 | — |
| Not listed | Rochester | Michigan | 48307 | — |
| Not listed | Troy | Michigan | 48085 | — |
| Not listed | Ypsilanti | Michigan | 48197 | — |
| Not listed | Minneapolis | Minnesota | 55407 | — |
| Not listed | Omaha | Nebraska | 68124 | — |
| Not listed | Hackensack | New Jersey | 07601 | — |
| Not listed | Neptune City | New Jersey | 07753 | — |
| Not listed | Newark | New Jersey | 07102 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Asheville | North Carolina | 28803 | — |
| Not listed | Greensboro | North Carolina | 27401 | — |
| Not listed | Fargo | North Dakota | 58102 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cleveland | Ohio | 44111 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Elyria | Ohio | 44035 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Toledo | Ohio | 43608 | — |
| Not listed | Portland | Oregon | 97225 | — |
| Not listed | Butler | Pennsylvania | 16001 | — |
| Not listed | Mechanicsburg | Pennsylvania | 17050 | — |
| Not listed | Wynnewood | Pennsylvania | 19096 | — |
| Not listed | York | Pennsylvania | 17403 | — |
| Not listed | Providence | Rhode Island | 02906 | — |
| Not listed | Greenville | South Carolina | 29605 | — |
| Not listed | Rock Hill | South Carolina | 29732 | — |
| Not listed | Knoxville | Tennessee | 37934 | — |
| Not listed | Dallas | Texas | 75226 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | McKinney | Texas | 75069 | — |
| Not listed | Tyler | Texas | 75701 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Virginia Beach | Virginia | 23454 | — |
| Not listed | Charleston | West Virginia | 25304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02389946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2022 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02389946 live on ClinicalTrials.gov.